Vyloo

Human Insulin 25 medicines online

About Human Insulin 25

Human Insulin 25 appears as an active ingredient (salt) in various prescription and OTC medicines. Use this page to browse related products listed on Vyloo and match strength and form to your prescription or prior purchase. Product information is educational for shopping only — it is not medical advice. Upload a valid prescription when the product is marked Rx.

View all results
Human Mixact InjectionRx

Human Mixact Injection

USV Ltd · 10.0 ml in 1 vial

₹423
Human Interact 40IU/ml InjectionRx

Human Interact 40IU/ml Injection

USV Ltd · 10.0 ml in 1 vial

₹158
Human Fastact 40IU/ml InjectionRx

Human Fastact 40IU/ml Injection

USV Ltd · 10.0 ml in 1 vial

₹143
Human Mixtard 40IU InjectionRx

Human Mixtard 40IU Injection

Abbott · 1.0 Injection in 1 vial

₹181
Human Mixtard 100IU InjectionRx

Human Mixtard 100IU Injection

Novo Nordisk India Pvt Ltd · 1.0 Injection in 1 vial

₹546
Human Mixtard 50 Injection 40IU/mlRx

Human Mixtard 50 Injection 40IU/ml

Novo Nordisk India Pvt Ltd · 10.0 ml in 1 vial

₹322
Human Actrapid 40IU/ml Solution for InjectionRx

Human Actrapid 40IU/ml Solution for Injection

Novo Nordisk India Pvt Ltd · 10.0 ml in 1 vial

₹181
Human Mixtard 70/30 Suspension for Injection 40IU/mlRx

Human Mixtard 70/30 Suspension for Injection 40IU/ml

Novo Nordisk India Pvt Ltd · 10.0 ml in 1 vial

₹181
Human Mixtard 70/30 Suspension for Injection 100IU/mlRx

Human Mixtard 70/30 Suspension for Injection 100IU/ml

Novo Nordisk India Pvt Ltd · 10.0 ml in 1 vial

₹546
Humarap 40IU/ml InjectionRx

Humarap 40IU/ml Injection

Cadila Pharmaceuticals Ltd · 10.0 ml in 1 vial

₹178
Huminsulin 50/50 Injection 100IU/mlRx

Huminsulin 50/50 Injection 100IU/ml

Eli Lilly and Company India Pvt Ltd · 1.0 Injection in 1 packet

₹383
Huminsulin 50/50 Suspension for Injection 40IU/mlRx

Huminsulin 50/50 Suspension for Injection 40IU/ml

Eli Lilly and Company India Pvt Ltd · 10.0 ml in 1 vial

₹210

Frequently asked questions

All salts · Health conditions · Editorial policy